SymbioCellTech
PrivateLast Round
Seed
Jun 24, 2016
Total Funding Raised
$7.5M
Company Overview
SymbioCellTech is a biotechnology company that develops stem cell-enabled therapies for the treatment of type 1 diabetes and other autoimmune and degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SymbioCellTech Comparables
Compare SymbioCellTech with similar companies based on industry and business-model similarity.
SymbioCellTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 24, 2016 | ||||
| Seed | Aug 15, 2014 | ||||
| Seed | Mar 20, 2013 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 37% MoM, reaching 973.
- Jun 24, 2016
$1.9M raised in Seed round
SymbioCellTech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SymbioCellTech's valuation, stock price, and market status.